English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51199889    Online Users :  779
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"ann lii cheng"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 241-250 of 690  (69 Page(s) Totally)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-01T01:54:18Z Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway Chou C.H.; Chen P.-J.; Jeng Y.-M.; ANN-LII CHENG; Huang L.-R.; Cheng J.C.-H.
臺大學術典藏 2021-09-01T01:54:18Z Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T.
臺大學術典藏 2021-09-01T01:54:18Z Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design Hsu C.; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:17Z Molecular targeted therapy for advanced hepatocellular carcinoma: Current status and future perspectives Shen Y.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:17Z Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions Shao Y.-Y.; Hu F.-C.; Liang J.-T.; Chiu W.-T.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:17Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:16Z Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation Chen K.-F.; Yu H.-C.; Liu T.-H.; Lee S.-S.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:16Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:16Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:16Z Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma Omata M.; Lesmana L.A.; Tateishi R.; Chen P.-J.; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K.

Showing items 241-250 of 690  (69 Page(s) Totally)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
View [10|25|50] records per page